Cannabis Law Report

DECEMBER 17, 2021

Deletion Syndrome – Global Market Insights, Epidemiology and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. deletion syndrome in the 7MM covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2018 to 2030. Country-Wise Epidemiology.

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Therapy 40

The Cannigma

OCTOBER 20, 2021

In a June, 2020 interview, a Swiss drug policy expert told Marijuana Business Daily that the scientific process behind the pilot program is expected to last five years, and that if everything goes as planned, the matter of full recreational cannabis legalization for adults could be debated by 2030. Is CBD legal in Switzerland?

Legalization 52

Legalization Decriminalization Patients Medicine 52

Cannabis Law Report

SEPTEMBER 15, 2021

The cannabis industry is experiencing explosive growth and is expected to be a $100 billion-dollar industry by 2030, but the opportunity is not shared equally,” said Jeffrey Sampson, CEO and Founder of Everscore. “We About Everscore.

Cultivation 52

Cultivation Supply Chain Agriculture Cannabis 52

Cannabis Law Report

JULY 28, 2022

Recently, C4 Ventures invested in cannabis company Cannaray, eyeing the wider European market for medicinal cannabis and CBD products. Cannaray is a European medical cannabis and retail CBD company that also received financial backing from Three Bridges Private Capital and Alpha Blue Ocean. ” Cannabis health benefits. .

Legislation 52

Legislation CBD Media Recreational 52

The Joint Blog

NOVEMBER 1, 2022

With the legal market projected to grow to over 27 million pounds by 2030, there’s a lot of potential for profit. The company has been in the business for over 20 years and has access to some of the best strains and genetics. You can get autoflower seeds, feminized seeds, CBD seeds, and regular weed seeds at amazing discounts.

Seed-To-Sale 49

Seed-To-Sale Strains Cannabis Access 49

Cannabis Law Report

JUNE 24, 2021

Messages must be fact-based and a clear distinction must be made among the effective medical uses of cannabis products for some ailments, the use of cannabis products such as CBD in the so-called wellness industry and the consequences of the non-medical use of cannabis. According to the latest global estimates, about 5.5

Research and Development 99

Research and Development Supply Chain Pharmaceutical Treatment 99